Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples